Phil Pharmacy Solutions LLC

Jennerex Biotherapeutics Inc, based in San Francisco, CA, is a global leader in oncolytic immunotherapeutics, specializing in targeting, attacking, and eradicating cancers. Their most advanced product candidate, Pexa Vec, is engineered to selectively infect and replicate in cancer cells by leveraging genetic changes common in cancer cells. In addition to Pexa Vec, Jennerex Biotherapeutics is actively developing their next-generation pipeline, JX 970, which has shown promising tumor debulking effects and a selective preference for tumor tissues in preclinical studies. The company is dedicated to advancing innovative treatments for cancer through strategic partnerships and ongoing research efforts. Generated from the website

Founded in 1980, Celgene Corporation is a full-service, multinational biopharmaceutical company. It has been approved by the Food Drug and Administration to market the THALOMID brand products used in the treatment of erythema nodosum leprosum. The company offers products from the VIDAZA, REVLIMID and ALKERAN brands. Celgene Corporation provides placental and cord blood banking services through LifebankUSA. The company conducts investigation compound studies on patients with hematological and solid tumor cancers, including multiple myeloma, myelodysplastic syndrome, chronic lymphocyte leukemia and glioblastoma. It also offers research and development, patient support and medical services for individuals. Celgene Corporation has a staff of more than 1,500 employees.

Aimmune Therapeutics is a biopharmaceutical company based in Brisbane, CA, that is dedicated to developing innovative medicines for the treatment, prevention, and management of food, gastrointestinal (GI), and metabolic-related diseases. As a Nestlé Health Science company, Aimmune aims to be a global leader in this field, providing standardized, science-driven treatments for patients and their families who have limited or no other options. With a focus on reducing the burden of serious and potentially life-threatening conditions, Aimmune pushes the boundaries of medicine to enable individuals to live life on their own terms. By uniting the best minds in clinical research and biotechnology, the company is actively working on its pipeline of therapies to address these diseases and improve the lives of patients and caregivers.Generated from the website